ANDREW KESTER: Open Payments
NPI 1619488053 · CEDAR PARK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,966 in 143 payments from 16 companies in 2025. Trend: 2023 $1,099 · 2024 $856 · 2025 $4,966
Food & beverage: $3,082Consulting: $1,800Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 23 | $1,894 |
| ABBVIE INC. | 30 | $1,365 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 20 | $384 |
| QOL Medical, LLC | 9 | $267 |
| PFIZER INC. | 18 | $245 |
| Aimmune Therapeutics, Inc. | 19 | $182 |
| Lilly USA, LLC | 5 | $137 |
| Ardelyx, Inc. | 4 | $91 |
| GENZYME CORPORATION | 3 | $90 |
| Celltrion USA Inc. | 4 | $80 |
Products named: TREMFYA, SKYRIZI, XIFAXAN, RINVOQ, Sucraid, ZENPEP, VELSIPITY, OMVOH.
Industry payments across TX — which companies pay providers there.
